-
1
-
-
73949120475
-
Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia
-
Chang H, Jiang AM, Qi CX. Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia. Am J Clin Pathol. 2010;133:70-74.
-
(2010)
Am J Clin Pathol
, vol.133
, pp. 70-74
-
-
Chang, H.1
Jiang, A.M.2
Qi, C.X.3
-
2
-
-
0034727833
-
Genomic aberrations and survival in chronic lymphocytic leukemia
-
DOI 10.1056/NEJM200012283432602
-
Donher H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910-1916. (Pubitemid 32064784)
-
(2000)
New England Journal of Medicine
, vol.343
, Issue.26 I
, pp. 1910-1916
-
-
Dohner, H.1
Stilgenbauer, S.2
Benner, A.3
Leupolt, E.4
Krober, A.5
Bullinger, L.6
Dohner, K.7
Bentz, M.8
Lichter, P.9
-
3
-
-
54049141334
-
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: Results from a detailed genetic characterization with long-term follow-up
-
Zenz T, Kröber A, Scherer K, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood. 2008;112:3322-3329.
-
(2008)
Blood
, vol.112
, pp. 3322-3329
-
-
Zenz, T.1
Kröber, A.2
Scherer, K.3
-
4
-
-
61549089361
-
The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of del17p13: Implications for overall survival and chemorefractoriness
-
Rossi D, Cerri M, Deambrogi C, et al. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of del17p13: implications for overall survival and chemorefractoriness. Clin Cancer Res. 2009;15:995-1004.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 995-1004
-
-
Rossi, D.1
Cerri, M.2
Deambrogi, C.3
-
5
-
-
0028085611
-
Detection of p53 mutations in hematological malignancies: Comparison between immunocytochemistry and DNA analysis
-
Lepelley P, Preudhomme C, Vanrumbeke M, et al. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia. 1994;8:1342-1349. (Pubitemid 24262491)
-
(1994)
Leukemia
, vol.8
, Issue.8
, pp. 1342-1349
-
-
Lepelley, P.1
Preudhomme, C.2
Vanrumbeke, M.3
Quesnel, B.4
Cosson, A.5
Fenaux, P.6
-
6
-
-
17744410949
-
P53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis
-
Cordone I, Masi S, Mauro FR, et al. p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood. 1998;91:4342-4349. (Pubitemid 28261999)
-
(1998)
Blood
, vol.91
, Issue.11
, pp. 4342-4349
-
-
Cordone, I.1
Masi, S.2
Mauro, F.R.3
Soddu, S.4
Morsilli, O.5
Valentini, T.6
Vegna, M.L.7
Guglielmi, C.8
Mancini, F.9
Giuliacci, S.10
Sacchi, A.11
Mandelli, F.12
Foa, R.13
-
7
-
-
0037103257
-
Multivariate analysis of prognostic factors in CLL: Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors
-
Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 2002;100:1177-1184.
-
(2002)
Blood
, vol.100
, pp. 1177-1184
-
-
Oscier, D.G.1
Gardiner, A.C.2
Mould, S.J.3
-
8
-
-
0037103212
-
H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
-
Kröber A, Seiler T, Benner A, et al. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410-1416. (Pubitemid 34864299)
-
(2002)
Blood
, vol.100
, Issue.4
, pp. 1410-1416
-
-
Krober, A.1
Seiler, T.2
Benner, A.3
Bullinger, L.4
Bruckle, E.5
Lichter, P.6
Dohner, H.7
Stilgenbauer, S.8
-
9
-
-
0028987180
-
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
-
Dohner H, Fischer K, Bentz M, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood. 1995;85:1580-1589.
-
(1995)
Blood
, vol.85
, pp. 1580-1589
-
-
Dohner, H.1
Fischer, K.2
Bentz, M.3
-
10
-
-
33845543049
-
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: The EBMT transplant consensus
-
DOI 10.1038/sj.leu.2404441, PII 2404441
-
Dreger P, Corradini P, Kimby E, et al. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia. 2007;21:12-17. (Pubitemid 44921829)
-
(2007)
Leukemia
, vol.21
, Issue.1
, pp. 12-17
-
-
Dreger, P.1
Corradini, P.2
Kimby, E.3
Michallet, M.4
Milligan, D.5
Schetelig, J.6
Wiktor-Jedrzejczak, W.7
Niederwieser, D.8
Hallek, M.9
Montserrat, E.10
-
11
-
-
0025951144
-
p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
-
Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1991;88:5413-5417.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 5413-5417
-
-
Gaidano, G.1
Ballerini, P.2
Gong, J.Z.3
-
12
-
-
0042744791
-
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features
-
Guarini A, Gaidano G, Mauro FR, et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood. 2003;102:1035-1041.
-
(2003)
Blood
, vol.102
, pp. 1035-1041
-
-
Guarini, A.1
Gaidano, G.2
Mauro, F.R.3
-
13
-
-
0028071555
-
Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
-
Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878.
-
(1994)
Cancer Res
, vol.54
, pp. 4855-4878
-
-
Greenblatt, M.S.1
Bennett, W.P.2
Hollstein, M.3
-
14
-
-
58049195581
-
Chronic lymphocytic leukemia and treatment resistance in cancer: The role of the p53 pathway
-
Zenz T, Benner A, Döhner H, et al. Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway. Cell Cycle. 2008;7:3810-3814.
-
(2008)
Cell Cycle
, vol.7
, pp. 3810-3814
-
-
Zenz, T.1
Benner, A.2
Döhner, H.3
|